| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $33.49K | $54.71K | $37.59K | $46.42K | $32.15K |
| R&D | – | – | – | – | – |
| SG&A | $33.49K | $54.71K | $37.59K | $46.42K | $32.15K |
| Operating Income | -$33.49K | -$54.71K | -$37.59K | -$46.42K | -$32.15K |
| Interest Expense | $7.50K | $3.51K | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$41.15K | -$58.21K | -$37.14K | -$46.42K | -$32.15K |
| EPS (basic) | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0100 |
| EPS (diluted) | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0100 |
| Shares (diluted) | $5.92M | $5.92M | $5.92M | $5.92M | $3.62M |